tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Simcere Pharmaceutical Grants 1.77 Million RSUs to Employees

Story Highlights
Simcere Pharmaceutical Grants 1.77 Million RSUs to Employees

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest update is out from Simcere Pharmaceutical Group Limited ( (HK:2096) ).

Simcere Pharmaceutical Group Limited announced the grant of 1,777,000 restricted share units (RSUs) to 45 employees under its 2021 RSU Scheme. This grant, which requires no purchase price, is aimed at incentivizing employees and aligning their performance with the company’s business goals. The RSUs will vest over a period of three years, contingent upon the achievement of individual and group performance targets, potentially impacting employee motivation and company performance.

More about Simcere Pharmaceutical Group Limited

Simcere Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating in the pharmaceutical industry. It focuses on the development and distribution of pharmaceutical products.

YTD Price Performance: 10.28%

Average Trading Volume: 4,809,891

Technical Sentiment Signal: Sell

Current Market Cap: HK$19.47B

For a thorough assessment of 2096 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1